Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.
Pulsed field ablation offers high success rate for irregular heart rhythms ...
In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...
Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...
Adagio Medical (Nasdaq:ADGM) today announced new six-month results from its FULCRUM-VT clinical trial evaluating its ablation technology.
The FULCRUM-VT trial evaluated the clinical utility of ultra-low temperature ablation for treating ventricular tachycardia in ...
Aqua Medical today announced the presentation of 12-month follow-up data for its proprietary radiofrequency vapor ablation ...
MedPage Today on MSN
Novel Pulsed Field Ablation System Turns to High-Energy, Ultra-Short Zaps
CellFX marks another route for Afib ablation technology ...
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results